NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientifi...

Related Keywords

United Kingdom ,Marie Mcavoy ,Joe Healey ,University Of Warwick Medical School ,Oncology Cell Therapy Research Unit ,Sciad Communications Ltd ,We Are Pioneer Group ,Sciad Newswire ,Chief Scientific ,Senior Director ,Oncology Cell Therapy Research ,Chief Executive Officer ,With Marie ,Octopus Ventures ,Dare Pioneer ,